ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CVG CSPC Pharmaceutical Group Limited

0.744
-0.0002 (-0.03%)
01 Jul 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
CSPC Pharmaceutical Group Limited TG:CVG Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0002 -0.03% 0.744 0.7224 0.7656 0.7656 0.7226 0.7656 2,534 22:50:08

Convergys Posts Narrower 3Q Loss, Gives Upbeat 4Q Earns View

27/10/2009 1:03pm

Dow Jones News


CSPC Pharmaceutical (TG:CVG)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more CSPC Pharmaceutical Charts.

Convergys Corp.'s (CVG) posted a narrower third-quarter loss on smaller write-downs, as well as new business signings and continuing solid margins in its customer-management business.

The provider of integrated billing, employee care and customer-care services also forecast fourth-quarter earnings, excluding items, of at least 30 cents a share on revenue of $650 million to $670 million. Analysts were expecting earnings of 26 cents a share on revenue of $667 million.

Business-services providers have been hurt by an overall pullback in corporate spending as the economy languishes.

Convergys said its third-quarter loss narrowed to $86 million, or 70 cents a share, from $140 million, or $1.15 a share. Excluding charges, including a year-ago $272.9 million charge related to human resources management contracts, earnings fell to 27 cents a share from 29 cents a share.

Revenue rose 13% to $765.4 million, including $106 million in deferred revenue from an HR-unit contract.

Analysts polled by Thomson Reuters were expecting earnings, excluding items, of 23 cents a share on revenue of $653 million.

Customer-management profit, excluding items, rose 61% on a 2% revenue rise and sharply higher margins. The much-smaller information-management segment, which offers bill processing services and software to telecommunications companies, had a 47% earnings drop as revenue fell 26%.

Convergys shares closed at $10.66 and didn't trade premarket. The stock has surged 66% this year.

-By Mike Barris, Dow Jones Newswires; 212-416-2330; mike.barris@dowjones.com

 
 

1 Year CSPC Pharmaceutical Chart

1 Year CSPC Pharmaceutical Chart

1 Month CSPC Pharmaceutical Chart

1 Month CSPC Pharmaceutical Chart

Your Recent History

Delayed Upgrade Clock